Its expression levels were investigated in 82 paired (tumor/adjacent) patient samples representing different liver lesions: HCC, CCA, combined HCC‐CCA, HBL, and benign tumors [78]. The gene discussed is LGALS1; the disease is cholangiocarcinoma.